CD40 Ligand

CD40 Ligand 분자 정보

영어 이름CD40 ligand시판 약물 수0
임상 약물 수14표적 별명CD154 Antigen,HCD40L,CD154,TNFSF5,CD40L,CD40 ligand, soluble form,CD40 ligand, membrane form,Tumor necrosis factor ligand superfamily member 5,T-cell antigen Gp39,CD40-L,CD40LG,TNF-Related Activation Protein,Tumor Necrosis Factor (Ligand) Superfamily Member 5,T-B Cell-Activating Molecule,T-BAM,HIGM1,Gp39,IMD3,IGM,CD40 Ligand,CD40 Antigen Ligand,TRAP,Tumor Necrosis Factor (Ligand) Superfamily, Member 5 (Hyper-IgM Syndrome),Hyper-IgM Syndrome,sCD40L
최고 연구 개발 단계Phase 3 Clinical
영어 이름CD40 ligand
표적 별명CD154 Antigen,HCD40L,CD154,TNFSF5,CD40L,CD40 ligand, soluble form,CD40 ligand, membrane form,Tumor necrosis factor ligand superfamily member 5,T-cell antigen Gp39,CD40-L,CD40LG,TNF-Related Activation Protein,Tumor Necrosis Factor (Ligand) Superfamily Member 5,T-B Cell-Activating Molecule,T-BAM,HIGM1,Gp39,IMD3,IGM,CD40 Ligand,CD40 Antigen Ligand,TRAP,Tumor Necrosis Factor (Ligand) Superfamily, Member 5 (Hyper-IgM Syndrome),Hyper-IgM Syndrome,sCD40L
시판 약물 수0
임상 약물 수14
최고 연구 개발 단계Phase 3 Clinical

CD40 Ligand분자 배경

CD40 ligand is also known as CD40L, CD154, TNFSF5 and T-cell antigen Gp39, is a single-pass type I I membrane protein which belongs to the TNF superfamily of molecules. CD40 ligand is expressed predominantly on activated CD4+ T lymphocytes, and also found in other types of cells, including platelets, mast cells, macrophages, basophils, NK cells, B lymphocytes, as well as non-haematopoietic cells (smooth muscle cells, endothelial cells, and epithelial cells). Although all monomeric, dimeric and trimeric forms of soluble CD40 ligand can bind to CD40, the trimeric form of soluble CD40 ligand has the most potent biological activity through oligomerization of cell surface CD40, a common feature of TNF receptor family members. CD40 ligand binds to CD40 on antigen-presenting cells (APC), which leads to many effects depending on the target cell type. In general, CD40 ligand plays the role of a costimulatory molecule and induces activation in APC in association with T cell receptor stimulation by MHC molecules on the APC. In total CD40 ligand has three binding partners: CD40, α5β1 integrin and αIIbβ3. CD40 ligand regulates B cell function by engaging CD40 on the B cell surface. A defect in this gene results in an inability to undergo immunoglobulin class switch and is associated with hyper IgM syndrome.

CD40 Ligand분자 별명

CD40LG,CD154,CD40L,HIGM1,IGM,IMD3,T-BAM,TNFSF5,TRAP,gp39

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
Dapirolizumab pegolAnti-CD40L-Fab; Anti-CD40L-Fab-PEG; CDP-7657; CD40L - Fab; BIIB-133Phase 3 ClinicalBiogen Inc, UcbAutoimmune Diseases; Connective Tissue Diseases; Immune System Diseases; Lupus Erythematosus, Systemic; Skin and Connective Tissue Diseases
상세
DazodalibepVIB-4920; MEDI-4920; HZN-4920(Horizon Therapeutics); UNII-HN5US76BWF; WHO-11399Phase 3 ClinicalHorizon Therapeutics PLC, Medimmune LlcArthritis, Rheumatoid; Graft Rejection; Lupus Nephritis; Rejection of renal transplantation; Sjogren's Syndrome; Sjogren-Larsson Syndrome
상세
FrexalimabINX-021; SAR-441344Phase 3 ClinicalImmunext IncDiabetes Mellitus, Type 1; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; Lupus Erythematosus, Systemic; Multiple Sclerosis; Nephrosis; Rejection of renal transplantation; Sjogren's Syndrome; Sjogren-Larsson Syndrome
상세
Anti-CD40L antibody (Bristol-Myers Squibb)Phase 2 ClinicalBristol-Myers Squibb CompanyImmunologic Deficiency Syndromes
상세
TegoprubartAT-1501Phase 2 ClinicalAls Therapy Development InstituteAmyotrophic Lateral Sclerosis; Diabetes Mellitus, Type 1; Glomerulonephritis, IGA; Rejection of renal transplantation
상세
Delolimogene mupadenorepvecLOAd-703Phase 2 ClinicalLokon Pharma, Uppsala UniversityBiliary Tract Neoplasms; Colorectal Neoplasms; Melanoma; Ovarian Neoplasms; Pancreatic Neoplasms
상세
TNX-1500TNX-1500Phase 2 ClinicalTonix Pharmaceuticals Holding CorpAutoimmune Diseases; Autoimmune Diseases of the Nervous System; Rejection of renal transplantation; Rejection of organ transplantation
상세
Base-edited hematopoietic stem and progenitor cells therapy (NIAID)Phase 2 ClinicalNational Institute Of Allergy And Infectious Diseases (Niaid)Hyper-IgM Immunodeficiency Syndrome, Type 1
상세
CD40 ligand expressing MSLN-CAR T cellsPhase 2 ClinicalPla General HospitalSolid tumours
상세
LetolizumabBMS-986004; BMS2h-572-633-CT-L2Phase 1 ClinicalBristol-Myers Squibb CompanyGraft vs Host Disease; Purpura, Thrombocytopenic, Idiopathic
상세
MEM-288MEM-288Phase 1 ClinicalMemgenCarcinoma, Merkel Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Melanoma; Neoplasm Metastasis; Neoplasms; Pancreatic Neoplasms; Solid tumours; Triple Negative Breast Neoplasms
상세
IBI355IBI-355Phase 1 ClinicalLupus Erythematosus, Systemic; Sjogren's Syndrome
상세
CD40L-augmented Tumor Infiltrating Lymphocytes (H Lee Moffitt Cancer Center & Research Institute)Phase 1 ClinicalH Lee Moffitt Cancer Center & Research InstituteCarcinoma, Non-Small-Cell Lung
상세
Lu-AG22515APB-A1; Lu-AG22515Phase 1 ClinicalAprilBio Co LtdGraves Ophthalmopathy; Neuromyelitis Optica
상세
  • 분자 정보
  • 제품 목록
  • 임상 약물 정보